Employee-Paid

For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.

A stop-loss market veteran looks at the differences between the two types of ERISA self-funded plans.

The move might, or might not, affect employers that fail to offer enough affordable major medical coverage.

The Idaho Farm Bureau Federation asked EBSA to assess a health coverage purchasing strategy it has proposed for its 10,770 members.

The U.S. Supreme Court on Monday issued an administrative stay that restores telehealth and mail access to the abortion pillmifepristone through May 11.

Renaissance CEO Diana Steinoff talks about how to sort from upselling from what workers really need to hear.